Updated:
ATEM Capital
ATEM Capital is a New York-based private equity firm investing from seed to late-stage growth across venture opportunities.
ATEM Capital
ATEM Capital invests in innovations across the Life Sciences industry. We work in partnership with leading venture capital groups in the US and EU.
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
New York
Corporate office
New York, United States
Frequently asked questions
What investment stages does ATEM Capital target?
ATEM Capital indicates a strategy covering early-stage, seed, and start-up investments, as well as expansion and late-stage growth. It is categorized as a general venture investor, suggesting participation across the full venture lifecycle rather than a single-stage focus. No further breakdown by check size or stage allocation is publicly available.
Does ATEM Capital disclose its assets under management?
ATEM Capital does not publicly disclose its assets under management. No regulatory filings, press releases, or website disclosures provide a current AUM figure. The firm's public footprint offers no basis for an estimate.
Who runs investment decisions at ATEM Capital?
ATEM Capital does not publish a team roster, investment committee details, or biographies of its principals. Its website at www.atemcap.com does not list personnel, and the firm has no known LinkedIn profile. The identities of those making investment decisions remain undisclosed.
Is ATEM Capital structured as a single family office or does it operate more like a venture firm?
ATEM Capital is classified as an asset manager operating as a private equity firm, not a family office. Its stated strategy is venture-oriented, covering seed to growth stages. There is no indication of a single-family wealth origin or a multi-family-office structure.
Which sectors does ATEM Capital invest in?
ATEM Capital does not publicly disclose sector preferences or restrictions. Its strategy is described in stage-based terms — early-stage, seed, start-up, expansion, and late-stage growth — without naming specific industries. No portfolio companies are named that would indicate a sector concentration.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: